Sintecabio ranked among the top searched stocks for 10 days in the past month.


As of 12:30 PM on the 7th, Sintecabio is trading at 41,550 KRW, down 2.35% from the previous day. This represents a 73.12% increase compared to September 21. Sintecabio is known as a genomic big data research company.

Today, foreigners are tentatively recorded as net sellers of 7,000 shares. Over the past five days, individual investors have net purchased 47,557 shares, while foreigners and institutions have net sold 71,970 shares and net purchased 445 shares, respectively.


On September 29, Sintecabio became a market issue with the headline "COVID-19 treatment efficacy Remdesivir doubled, hitting the upper price limit."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing